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Abstract 
Stroke is the one of the leading causes of mortality and 
morbidity in developed countries.   The central role of 
injury to white matter in the pathophysiology of stroke has 
been recognised over the recent years.  Stroke can affect a 
wide range of the population (from the premature infant to 
the elderly) and therefore the mechanism of injury of 
central white matter may vary with age.  The main aim of 
this review paper is to shed some light on the difference in 
maturation of injury to the axon-oligodendrocyte unit 
following an ischemic insult between different 
developmental stages.  Both components of this unit 
exhibit varying degrees of susceptibility to ischemia 
throughout their development.  Axons are particularly 
resistant to ischemia in the neonatal stage.  However, they 
show a marked decreased in tolerance to ischemia during 
the period of myelination.  Late oligodendrocyte 
progenitor cells (OPC) are the most sensitive type of 
oligodendrocyte, and their role in periventricular 
leukomalacia (PVL) is well known.  On the other hand, 
early OPC are particularly resistant to ischemia.  Studying 
the effect of ischemia on white matter in the brain during 
the different developmental stages will lead to a better 
understanding of the pathophysiology of white matter 
injury and hopefully, in the future, to the development of 
new therapeutic strategies of the various white matter 
diseases. 
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Incidence of stroke 
Stroke is a leading cause of serious long-term disability 
in the world.  According to World Health Organisation 
data 15 million people suffer from stroke worldwide 
yearly.1 Stroke is listed as being the second most common 
cause of death worldwide, and the leading cause of long-
term disability in the United States.2  
 
Stroke was long thought to be a disease that affects only 
the elderly, and stroke in neonates was considered a rare 
occurrence.  However, the care of premature infants has 
improved significantly over the past years, resulting in a 
marked improvement of the survival of very low birth 
weight infants (< 1.5 kg).  In the U.S. 1.5% of all births are 
very low birth weight (around 65,000 per year), and 90% 
of these survive the neonatal period.3  Sadly, around 10% 
of these survivors later develop spastic motor deficits 
(cerebral palsy)4 and around 25-50% later exhibit cognitive, 
attentional, behavioural, and/or socialisation defects that 
significantly impair their quality of life.5-6  
 
Importance of white matter in stroke 
The traditional view that gray matter is the single 
contributing factor to the outcome of stroke has recently 
been challenged.  Animal studies in the past showed that 
gray matter is more vulnerable than white matter.7 This 
might be due to the fact that most of the experimental 
work done on stroke utilised rodents as animal models.  In 
rodents, white matter constitutes only 13% of total brain 
volume.8 Therefore, white matter injury was often 
overlooked and given less importance.  However in 
humans, white matter accounts for almost 50% of total 
brain volume8, and the metabolic rate of white matter is 
only modestly reduced when compared to that of grey 
matter.9  Moreover, any ischemic stroke will affect similar 
proportions of grey and white matter, and it is never 
limited to gray matter alone.  
 
White matter injury in neonatal stroke 
Clinical interest in ischemic injury to developing white 
matter has recently increased considerably.  Although the 
immature central nervous system (CNS) is regarded to be 
more resistant than the adult, it is now known that any 
ischemic insult between 23 and 32 weeks gestation can 
result in a remarkably selective pattern of injury known as 
PVL.10  In fact, PVL is the most common cause of brain 
injury in the premature infant.11   
The pathogenesis of white matter injury in the neonate is 
different from that in the adult.  Volpe and colleagues 
summarise the pathogenesis of PVL into three major 
interacting factors: cerebral ischemia, systemic infection 
and inflammation, and maturation-dependent intrinsic 
vulnerability of pre-myelinating oligodendrocytes.12 
 
Myelination of the CNS and oligodendrocyte 
development 
Myelination of the CNS is a well-controlled and 
systematic process that occurs in an orderly spatial and 
temporal sequence (Fig 1). All CNS neurons are 
formed before birth, while white matter begins to from 
only in the third trimester of gestation.13 The process 
of white matter development is not complete at birth, 
and it is still only 90% complete by 2 years of age.14 In 
the neonate, myelination is restricted only to the basal 
ganglia, and sensory fibres passing up from the spinal 
cord. After birth, the tectospinal, corticospinal, 
corticobulbar, and corticopontocerebellar fibers begin 
to myelinate.15 Posterior regions of the brain myelinate 
prior to anterior regions.16 The last fibres to myelinate 
are the inter-cortical association neurons, while 
myelination in the frontal lobes occurs into 
adolescence and early adulthood.17  
 
 
Figure 1 – Cycles of myelination in the CNS during 
development. The width and the length of graphs indicate 
progression in density of myelinated fibers; the vertical 
stripes at the end of the graphs indicate approximate age 
range of termination of myelination (taken from 1). 
 
Oligodendrocyte development can be characterised 
into four stages: early oligodendrocyte progenitor cells 
(OPC), late OPC (also called premyelinating 
oligodendrocytes), immature myelinating 
oligodendrocyte, and mature myelinating 
oligodendrocyte (Fig. 2).18 Early OPC are small 
bipolar cells that start forming around 13 weeks 
gestation in humans.  They can be identified by the 
NG2 antigen.  These cells differentiate into a simple 
multipolar, mitotically active late OPC at 20 week 
gestation. They are identified mainly with O4 
antibodies but not with O1 (NG2 is still present at this 
stage).  The immature myelinating oligodendrocyte is 
a postmitotic complex multipolar cell identified by the 
O1 antibody.  The mature oligodendrocyte undergoes 
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extensive cellular growth and process elaboration and is 
identified by a variety of myelin-associated markers that 
include myelin basic protein.19-23 
 
 
 
Figure 2 – Oligodendrocytes lineage. Successive stages are 
characterised by increasingly complex morphology and by 
different antigenic marker (taken from 18) 
 
Axonal ischemic injury during development 
In the past, the CNS of the neonatal mammal was 
regarded to be more resistant to ischemia than that of the 
adult.24-25  Researchers proposed that this might be a safety 
mechanism of the neonate, since the neonatal brain is more 
prone than the adult to suffer from periods of 
hypoperfusion during the pre- and post-natal period.26-27 
However, prolonged neonatal ischemia can result in 
extensive CNS injury, and some studies show that white 
matter structures are more vulnerable than gray matter 
during the neonatal period.28  
 
The sensitivity of rat gray matter to anoxia and 
aglycemia increases progressively from birth to adulthood, 
consistent with the rise in metabolic rate.29 White matter 
do not follow a similar pattern.  Fern and colleagues 
showed that neonatal white matter is very resistant to 
ischemia. Using optic nerves from neonatal mice (post-
natal day 2 (P2)), they found that it is tolerant to anoxia, 
aglycaemia, and combined anoxia and aglycaemia in terms 
of maintenance of evoked compound action potential, and 
shows a good recovery of function during reperfusion (Fig. 
3).30 We did a structural analysis of the OGD-induced 
damage to the optic nerve from a similar age group of 
mice, and confirmed such results (unpublished data) (Fig. 
4). This tolerance to ischemia may be attributed to the 
lower metabolic rate of neonatal white matter.24,31 
 
 
Figure 3 – The effect of 60 min OGD on the optic nerve 
compound action potential from rats of various ages.   
(A)  Change in magnitude of CAP plotted against time 
after initiation of OGD 60 min; (B) extent of CAP 
recovery after 60 min OGD plotted against age (taken 
from 30) 
 
 
 
Figure 4 – Summary data for axonal injury.  
There is progression of injury following all lengths of 
OGD which was most prominent in P20-50 mice 
(squares).  P <20 mice (diamond) were the most resistant 
to injury. * p < 0.001 (ANOVA) (unpublished data) 
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In mice, there is a period of heightened sensitivity to 
ischemia from postnatal day 20 to 50.  In fact, 60 mins of 
OGD induces a complete loss of CAP with no recovery of 
function in this age group (Fig. 3).30  Again, results from 
our experiments on the effect of ischemia on structural 
integrity of axons show that the degree of ischemia 
induced injury in this age group is higher than older and 
younger mice (unpublished data) (Fig. 4).  This period of 
heightened sensitivity is dominated by the process of 
myelination.  The rodent optic nerve starts myelination at 
around P7 with only few axons having just a single layer 
of myelin at this age.32  The rate of myelin deposition is 
maximal between P21 and P28, and from this point 
onward, the process of myelination is at its highest.33  
Therefore, the period of low tolerance to ischemia found 
between P20 and P50, may be attributed to the heightened 
metabolic activity associated with the anabolic process of 
myelination.34-35  Besides myelination, other factors may 
contribute to this increases susceptibility to ischemic 
injury.  The Na+ channel density in optic nerve axons 
varies with age: starting from < 2/µm2 in the neonate36, 
increases up to the age of around P25, followed by a 
decrease in adulthood.37  During myelination, these Na+ 
channels aggregate at the nodes of Ranvier, and the change 
in density of Na+ channels results in a persistent Na+ 
current, which exacerbates white matter injury following 
anoxia.38  Ca2+ currents increase in magnitude in the 
postnatal period39, and Ca2+ channels were shown to 
contribute directly to anoxic injury in white matter.40 
 
The fact that ischemic damage is dependent on the 
white matter developmental stage, leads to another 
question.  Is the mechanism of injury the same during 
the different stages?  Tekkök and Goldberg showed 
that AMPA/Kainate receptor activation, and Ca2+ 
influx are essential in the maturation of axonal injury 
to white matter in adults.  In fact, blocking of 
AMPA/Kainate receptors and Ca2+ removal from the 
perfusate preserves oligodendrocytes and axonal 
structure and function.41  On the other hand, McCarren 
and Goldberg found that in P3 mice, AMPA/Kainate 
receptor agonists do not damage axons, and 
antagonists do not prevent ischemic axonal damage 
(Fig 5).  Similar results to those obtained by Tekkök 
and Goldberg (2001) were achieved by this group 
when older mice (older than postnatal day 20) were 
used.  In this age group, AMPA exposure damages 
axons, and AMPA/Kainate blockade results in 
preservation of axonal structure (Fig 5). McCarren and 
Goldberg  proposed that there might be some change 
in the intrinsic properties of oligodendrocytes and 
axons during this developmental stage.42   
 
 
 
Figure 5 – Effect of AMPA agonists on P3 and P21 mice. AMPA agonists induced damage in P21 mice 
(B), but not in P3 mice (A) (taken from 42) 
 
 
Vulnerability of the various oligodendrocyte 
developmental stages to ischemia 
Oligodendrocyte are vulnerable to ischemia, and their 
sensitivity varies with each developmental stage.  As 
discussed before, there are four stages of oligodendrocyte 
development: early OPC, late OPC, immature 
myelinating oligodendrocyte, and mature myelinating 
oligodendrocyte.  
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Early OPC are the most resistant type to ischemia, with 
late OPC being the most sensitive.43  Back and colleagues 
used brain slices containing corpus callosum from P2 mice 
to study the relative susceptibility of early OPC, late OPC, 
and immature oligodendrocytes.  After induction of OGD, 
early OPC appear hypertrophic, with thickened proximal 
processes, and a more elaborate process arbor (Fig 6 (A) 
arrowheads), thus confirming their resistance to ischemia.  
In contrast, following ischemia late OPC exhibit 
widespread degeneration (Fig 6 (A) arrows), and the 
density of pyknotic (dead) late oligodendrocyte 
progenitors is significantly higher than that of immature 
oligodendrocytes (Fig 6 (B)).43  This maturation-dependant 
sensitivity of late OPC to ischemia is one of main causes 
leading to preferential white matter injury in the neonate, 
i.e. to PVL12, since their development coincides with the 
high-risk period of PVL in humans.44 
 
The major factors underlying the maturation-dependent 
susceptibility of the late OPC were summarised in a recent 
review paper by Volpe.  Briefly, the abundant production 
of both reactive oxygen species and reactive nitrogen 
species during PVL, the delayed development of 
antioxidant defences in late OPC, and the acquisition of 
Fe2+ by late OPC result in vulnerability of this cell to free 
radical attack.  Also, late OPC are very sensitive to 
excitotoxicity due to exuberant expression of the major 
glutamate transporter, of AMPA receptors deficient in the 
GluR2 subunit (and therefore Ca2+ permeable), and of 
NMDA receptors (which are also Ca2+ permeable).12    
 
 
 
Figure 6 – Maturation-dependant vulnerability in 
oligodendrocyte lineage.   
(A) Numerous reactive early OPC (red, arrowheads) in 
ischemic lesion in P2 animals overlapped with pyknotic late 
OPC (green, arrows); (B) Comparing number of pyknotic 
(dead) late OPC and immature oligodendrocytes following 
OGD (taken from 43). 
 
 
 
 
Fern and Moller studied the remaining two groups of 
oligodendrocyte development stages, i.e. immature 
and mature oligodendrocyte, using cell cultures from 
P2 rats.  Mature oligodendrocytes  (A2B5– /GC+) are 
more resistant to ischemic damage than immature ones 
(O4+/GC–) (Fig 7).  They proposed that the rapid 
ischemic cell death of the immature oligodendrocytes 
is mediated by Ca2+ influx via non-NMDA glutamate 
receptors, and is exacerbated by a significant element 
of autologous feedback of glutamate from cells onto 
their own receptors.45 
 
 
Figure 7 – Comparing Mature (A2B¬5–/GC+) with 
immature (O4+/GC–) oligodendrocytes following OGD 
(taken from 45). 
 
 
 
Figure 8 – Summary data for percentage dead 
oligodendrocytes.   
The number of dead oligodendrocyte increased following 
all lengths of OGD with P < 20 mice (diamond) being 
most sensitive, and P > 50 mice (triangle) being most 
resistant to ischemic damage. * p< 0.05 (Chi-square test) 
(unpublished data) 
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In our experiments, we compared the susceptibility of 
the immature and mature myelinating oligodendrocyte to 
various lengths of OGD (unpublished data) using the 
mouse optic nerve from different developmental stages.  
We used the APC antibody, which is directed against APC 
(adenomatous polyposis coli), an intracellular antigen on 
myelinating oligodendrocytes.  We found that ischemia 
induces a higher percentage of dead APC positive 
oligodendrocyte (cells that were detected by APC 
antibody) in younger mice is higher than in older mice 
following the same ischemic insult (unpublished data) (Fig 
8).  Therefore, immature myelinating oligodendrocytes are 
more sensitive to OGD than the mature ones. 
 
Conclusions 
The period of increased tolerance to ischemia of white 
matter axons in mice coincides with the period of low 
metabolic demand in the unmyelinated axons present at 
that stage.  In human CNS, the degree of myelination of 
axons is very limited at birth.  The fact that unmyelinated 
axons seem to be more resistant to ischemia, might be 
advantageous to the neonate who is more prone to periods 
of hypoxia/ischemia than the adult.  On the other hand, the 
period of heightened sensitivity, matches the myelination 
stage of mice axons.  It would be interesting to investigate 
if myelinating axons in the human CNS are also more 
susceptible to ischemic injury than unmyelinated or fully 
myelinated axons.  The hypothetical period of increased 
sensitivity of axons in humans would be present around 
the first two years of life.  To our knowledge this was 
never documented in humans, and more studies on human 
subjects with childhood stroke are needed to investigate 
this theory. 
 
The maturation-dependent vulnerability of the late OPC 
to ischemic injury is one of the bases leading to PVL, and 
this fact is very well documented in literature.  In view of 
the intricate relationship between axons and 
oligodendrocytes, one would expect that oligodendrocytes 
would show a similar pattern of vulnerability to axons, i.e. 
a heightened sensitivity to ischemia during the myelination 
stage.  However, this was not the case, since in our study, 
we found that myelinating oligodendrocytes (detected with 
APC antibody) present in mice P<20 were more sensitive 
than their counterparts present during the myelination 
phase.  This discrepancy was never documented in 
literature, and further studies needs to be conducted to 
elucidate the exact mechanism behind this difference. 
 
Considering all these facts, one appreciates the 
importance of research in this area.  The 
pathophysiological mechanisms of white matter injury in 
stroke vary between different developmental stages.  
Understanding better these differences, might give new 
insights on developing new therapeutic modalities for 
such a challenging disease.  
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